Literature DB >> 3157451

Endogenous concentration and subcellular distribution of androgens in normal and malignant human breast tissue.

A A van Landeghem, J Poortman, M Nabuurs, J H Thijssen.   

Abstract

The endogenous concentrations and the subcellular distribution of dehydroepiandrosterone (DHEA) and 5-androstene-3 beta,17 beta-diol (ADIOL) were measured in malignant and nonmalignant human breast tissue from both pre- and postmenopausal women. DHEA 3-sulfate was measured only in the cytosol. A greater tissue-plasma gradient of DHEA was present with large variations. The highest concentration of DHEA and ADIOL occurred in the nuclear fraction (average, 2.9 and 1.6 times the concentration in cytosol). With respect to DHEA, this finding is remarkable because no specific binding protein in human breast tissue has been reported. The concentration of DHEA 3-sulfate was significantly higher in the cytosol of nonmalignant than in malignant breast tissues. No significant differences in tissue concentrations of DHEA and ADIOL were found in malignant and nonmalignant breast tissue. The concentration of estrogens was measured in the cytosol and the nuclear fraction of the same tissues, as reported in a previous paper. We found a significantly higher estradiol concentration in malignant tissue as compared to nonmalignant tissue. When the ratio of ADIOL to estradiol was calculated from the combined data, a significant difference was found only in the cytosol of premenopausal cancer patients versus normal women. No difference was seen in the postmenopausal women. No difference in the ADIOL:estradiol ratio was found between normal and malignant breast tissue of patients of the same menopausal status.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3157451

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

Review 1.  Aromatase, breast cancer and obesity: a complex interaction.

Authors:  Serdar E Bulun; Dong Chen; Irene Moy; David C Brooks; Hong Zhao
Journal:  Trends Endocrinol Metab       Date:  2011-12-12       Impact factor: 12.015

2.  Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.

Authors:  Mark P Thomas; Barry V L Potter
Journal:  J Med Chem       Date:  2015-06-12       Impact factor: 7.446

3.  Sex steroid hormone levels in breast adipose tissue and serum in postmenopausal women.

Authors:  Roni T Falk; Elisabet Gentzschein; Frank Z Stanczyk; Montserrat Garcia-Closas; Jonine D Figueroa; Olga B Ioffe; Jolanta Lissowska; Louise A Brinton; Mark E Sherman
Journal:  Breast Cancer Res Treat       Date:  2011-08-26       Impact factor: 4.872

Review 4.  Aromatase, estrone sulfatase, and 17β-hydroxysteroid dehydrogenase: structure-function studies and inhibitor development.

Authors:  Yanyan Hong; Shiuan Chen
Journal:  Mol Cell Endocrinol       Date:  2010-10-01       Impact factor: 4.102

5.  Predictive relevance of HOXB13 protein expression for tamoxifen benefit in breast cancer.

Authors:  Piiha-Lotta Jerevall; Agneta Jansson; Tommy Fornander; Lambert Skoog; Bo Nordenskjöld; Olle Stål
Journal:  Breast Cancer Res       Date:  2010-07-22       Impact factor: 6.466

Review 6.  Tracking progesterone receptor-mediated actions in breast cancer.

Authors:  Todd P Knutson; Carol A Lange
Journal:  Pharmacol Ther       Date:  2013-11-26       Impact factor: 12.310

7.  Aromatase excess in cancers of breast, endometrium and ovary.

Authors:  Serdar E Bulun; Dong Chen; Meiling Lu; Hong Zhao; Youhong Cheng; Masashi Demura; Bertan Yilmaz; Regina Martin; Hiroki Utsunomiya; Steven Thung; Emily Su; Erica Marsh; Amy Hakim; Ping Yin; Hiroshi Ishikawa; Sanober Amin; Gonca Imir; Bilgin Gurates; Erkut Attar; Scott Reierstad; Joy Innes; Zhihong Lin
Journal:  J Steroid Biochem Mol Biol       Date:  2007-05-24       Impact factor: 4.292

Review 8.  Minireview: Obesity and breast cancer: the estrogen connection.

Authors:  Margot P Cleary; Michael E Grossmann
Journal:  Endocrinology       Date:  2009-04-16       Impact factor: 4.736

Review 9.  The role of aromatase in breast tumors.

Authors:  M J Reed
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

10.  Expression of aromatase and estrogen sulfotransferase in preinvasive and invasive breast cancer.

Authors:  G Hudelist; P Wülfing; C Kersting; H Burger; B Mattsson; K Czerwenka; E Kubista; D Gschwantler-Kaulich; A Fink-Retter; C F Singer
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-28       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.